Vitamin D and Hip Fracture

Area of Science:

• Gerontology
• Orthopedics
• Public Health

Background:

• Hip fractures represent a significant and growing global public health concern.
• Projected increases in hip fractures, from 1.26 million in 1990 to 4.5 million by 2050, highlight the urgent need for effective prevention strategies.

Purpose of the Study:

• To review available preventive strategies for hip fractures.
• To assess the efficacy of calcium and vitamin D supplementation, bisphosphonate therapy, and hip protectors in reducing hip fracture incidence.

Main Methods:

• Review of existing literature on hip fracture prevention.
• Analysis of the impact of calcium and vitamin D on bone quality and fall risk.
• Evaluation of bisphosphonate alendronate's effect on bone strength.
• Assessment of hip protectors' energy-absorbing capabilities during falls.

Main Results:

• Vitamin D and calcium supplementation reduced hip fracture risk by 43% in vitamin D-insufficient elderly individuals.
• Bisphosphonate alendronate treatment resulted in a 51% reduction in hip fracture risk.
• Hip protectors demonstrated a 56% reduction in hip fracture risk by absorbing fall impact energy.

Conclusions:

• Preventive strategies, including nutritional supplementation, pharmacotherapy, and protective devices, are available and effective.
• Combining calcium and vitamin D, bisphosphonates, and hip protectors offers a promising approach to substantially decrease future hip fracture incidence.